P75 Stock Overview
Provides products and solutions for use of injectable drugs in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Perpetua Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.34 |
| 52 Week High | SEK 0.41 |
| 52 Week Low | SEK 0.0048 |
| Beta | 2.12 |
| 11 Month Change | 22.85% |
| 3 Month Change | 109.56% |
| 1 Year Change | 239.29% |
| 33 Year Change | -98.30% |
| 5 Year Change | n/a |
| Change since IPO | -97.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| P75 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.8% | 8.4% | 1.8% |
| 1Y | 239.3% | 8.3% | 13.8% |
Return vs Industry: P75 exceeded the German Medical Equipment industry which returned 8.3% over the past year.
Return vs Market: P75 exceeded the German Market which returned 13.8% over the past year.
Price Volatility
| P75 volatility | |
|---|---|
| P75 Average Weekly Movement | 52.5% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: P75's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: P75's weekly volatility has decreased from 156% to 53% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 4 | Anders Hedlund | perpetuamedical.se |
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.
Perpetua Medical AB (publ) Fundamentals Summary
| P75 fundamental statistics | |
|---|---|
| Market cap | €1.68m |
| Earnings (TTM) | -€746.11k |
| Revenue (TTM) | €555.64k |
3.0x
P/S Ratio-2.2x
P/E RatioIs P75 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| P75 income statement (TTM) | |
|---|---|
| Revenue | SEK 6.32m |
| Cost of Revenue | SEK 3.06m |
| Gross Profit | SEK 3.26m |
| Other Expenses | SEK 11.74m |
| Earnings | -SEK 8.48m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 22, 2024
| Earnings per share (EPS) | -1.88 |
| Gross Margin | 51.60% |
| Net Profit Margin | -134.28% |
| Debt/Equity Ratio | 0% |
How did P75 perform over the long term?
See historical performance and comparison